STOCK TITAN
  1. Home
  2. Sec-filings
  3. ATLN
  4. [Form 4] Atlantic International Corp. Insider Trading Activity

Atlantic International grants 264,860 restricted shares to General Counsel; vests 01/01/2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Atlantic International Corp. reported that Michael Tenore, General Counsel and an officer, was awarded 264,860 restricted shares on 08/11/2025 following a board review of senior management equity tied to the June 18, 2024 closing of the Lyneer Investments LLC acquisition.

The award carries a nominal conversion price of $0.0001, becomes exercisable or vests on 01/01/2026, does not have an expiration date, and raises Tenore’s reported beneficial ownership to 842,031 shares. The Form 4 records this as a direct acquisition of derivative securities converted into common stock.

Positive

  • Board-approved award of 264,860 restricted shares to Michael Tenore explicitly disclosed
  • Award has no expiration date, as stated in the filing
  • Beneficial ownership increased to 842,031 shares following the award

Negative

  • None.

Insights

TL;DR: Board granted 264,860 restricted shares to General Counsel, raising his stake to 842,031; award vests 01/01/2026.

The filing documents a sizable restricted stock award to an executive, showing direct alignment of compensation with equity ownership. The award's 264,860 share size and the post-award beneficial ownership of 842,031 are material facts for shareholder dilution and insider stake analysis. The nominal conversion price of $0.0001 and lack of an expiration date are explicit terms disclosed by the company.

Impact assessment: the transaction is noteworthy for ownership and compensation tracking but is disclosed as a standard equity award.

TL;DR: Award reflects board action to adjust senior management equity after the Lyneer acquisition; vests on 01/01/2026 with no expiration.

The Form 4 explicitly ties the grant to a board review of senior management equity following the June 18, 2024 acquisition of Lyneer Investments LLC. The absence of an expiration date and the documented vesting/exercise date of 01/01/2026 are governance-relevant details. This filing provides clear disclosure of the award's rationale and mechanics as presented by the issuer.

Impact assessment: governance disclosure is complete on the award terms; the filing itself is a routine, material disclosure of insider compensation changes.

Insider Tenore Michael
Role General Counsel
Type Security Shares Price Value
Grant/Award Restricted Stock Award 264,860 $0.00 --
Holdings After Transaction: Restricted Stock Award — 842,031 shares (Direct)
Footnotes (1)
  1. These shares were awarded by the Board of Directors on August 11, 2025, as the Company had agreed to review the equity compensation for senior management within one year of the June 18, 2024 closing date of the acquisition of Lyneer Investments LLC. This award does not have an expiration date.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tenore Michael
(Last) (First) (Middle)
270 SYLVAN AVENUE, SUITE 2230
(Street)
ENGLEWOOD CLIFFS, NJ 07632
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ATLANTIC INTERNATIONAL CORP. [ ATLN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
General Counsel
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Award(1) $0.0001 08/11/2025 08/11/2025 A 264,860 01/01/2026 (2) Common Stock 264,860 $0 842,031 D
Explanation of Responses:
1. These shares were awarded by the Board of Directors on August 11, 2025, as the Company had agreed to review the equity compensation for senior management within one year of the June 18, 2024 closing date of the acquisition of Lyneer Investments LLC.
2. This award does not have an expiration date.
/s/ Michael Tenore 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Michael Tenore receive according to the Form 4 for ATLN?

He received a Restricted Stock Award of 264,860 derivative securities convertible into common stock, with a nominal conversion price of $0.0001.

When was the ATLN award granted and when does it become exercisable?

The transaction date is 08/11/2025 and the award is recorded as exercisable/vesting on 01/01/2026.

How many shares does Michael Tenore beneficially own after the reported transaction (ATLN)?

Following the reported transaction, Tenore's beneficial ownership is 842,031 shares.

Why was the restricted stock award granted, per the filing for ATLN?

The filing states the shares were awarded by the Board on 08/11/2025 after the company agreed to review senior management equity within one year of the June 18, 2024 closing of the Lyneer Investments LLC acquisition.

Does the restricted stock award for ATLN have an expiration date?

No. The filing explicitly states this award does not have an expiration date.